HIV/AIDS
-
Safety and Immunogenicity of SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901 in People Living with HIV
This article has 18 authors:Reviewed by ScreenIT
-
High seroconversion rate and SARS-CoV-2 Delta neutralization in people with HIV vaccinated with BNT162b2
This article has 18 authors:Reviewed by ScreenIT
-
Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States
This article has 22 authors:Reviewed by ScreenIT
-
Tenofovir Disoproxil Fumarate and severity of COVID-19 in people with HIV infection
This article has 16 authors:Reviewed by ScreenIT
-
Factors Associated With Severity of COVID-19 Disease in a Multicenter Cohort of People With HIV in the United States, March–December 2020
This article has 29 authors:Reviewed by ScreenIT
-
Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV)
This article has 58 authors:Reviewed by ScreenIT
-
Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
This article has 43 authors:Reviewed by ScreenIT
-
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
This article has 58 authors:Reviewed by ScreenIT
-
Immunogenicity of an inactivated SARS-CoV-2 vaccine in people living with HIV-1: a non-randomized cohort study
This article has 15 authors:Reviewed by ScreenIT
-
Reduction in initiations of HIV treatment in South Africa during the COVID pandemic
This article has 6 authors:Reviewed by ScreenIT